RA Capital Nexus Fund, Director, 10% Stockholder: Sionna Therapeutics SION Planned sale · Filed 25/10/24

Trade details

Type: Planned sale notice
Stock: Sionna Therapeutics SION
Person: RA Capital Nexus FundDirector, 10% Stockholder
Planned sale date: 25/10/24
Filed: 25/10/24

0.3% of shares outstanding to be sold

Sionna Therapeutics trades, last 26 weeks

What else happened in Sionna Therapeutics around then

Filed or reported within 30 days of the trade day · 25/09/24~25/11/23

RA Capital Nexus Fund's recent trades

RA Capital Nexus FundDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$275.3K
31,000 sh
$275.3K
Filed 06/29
Traded 06/25
RA Capital Nexus FundDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$16.8K
1,876 sh
$16.8K
Filed 06/29
Traded 06/26
RA Capital Nexus FundDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$3.4M
391,019 sh
$3.4M
Filed 06/16
Traded 06/12
RA Capital Nexus FundDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$1.1M
124,893 sh
$1.1M
Filed 06/16
Traded 06/16
RA Capital Nexus FundDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$138.6K
15,414 sh
$138.6K
Filed 06/16
Traded 06/15

RA Capital Nexus Fund, 10% Owner — plans to sell 122,271 sh of Sionna Therapeutics SION · $4.8M · around 10/24 | Whalegun